Stay updated on AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial
Sign up to get notified when there's something new on the AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial page.

Latest updates to the AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was deleted from the record history.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision history now shows v3.4.3 added and v3.4.2 removed.SummaryDifference0.1%

- Check52 days agoChange DetectedThe record history now shows the addition of version v3.4.2 and the deletion of version v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check59 days agoChange DetectedThe Record History now includes a new revision entry v3.4.1 and removes the previous v3.4.0 entry.SummaryDifference0.1%

- Check81 days agoChange DetectedA new revision v3.3.4 was added to the history and the previous revision v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check103 days agoChange DetectedA new revision entry (v3.3.3) was added and older items ('HHS Vulnerability Disclosure' and 'Revision: v3.3.2') were removed.SummaryDifference0.2%

Stay in the know with updates to AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial page.